2,2,2-Trifluoroethyl N-[4-(3-fluorophenyl)-1,3-thiazol-2-yl]carbamate

Catalog No. :
ACVSXA099
CAS No. :
1311314-21-2
Molecular Formula :
C12H8F4N2O2S
Molecular Weight :
320.27

IUPAC Name:2,2,2-trifluoroethyl (4-(3-fluorophenyl)thiazol-2-yl)carbamate

2,2,2-Trifluoroethyl N-[4-(3-fluorophenyl)-1,3-thiazol-2-yl]carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$129.00Login to see priceInquiryInquiry
100mg95%$183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2,2-Trifluoroethyl N-[4-(3-fluorophenyl)-1,3-thiazol-2-yl]carbamate
IUPAC Name2,2,2-trifluoroethyl (4-(3-fluorophenyl)thiazol-2-yl)carbamate
MDL No.MFCD18483156
Molecular FormulaC12H8F4N2O2S
Molecular Weight320.27
SMILESO=C(OCC(F)(F)F)NC1=NC(C2=CC=CC(F)=C2)=CS1
InChI KeyRYTSUFZNSLUZRW-UHFFFAOYSA-N
Synonym2,2,2-trifluoroethyl N-[4-(3-fluorophenyl)-1,3-thiazol-2-yl]carbamate;Carbamic acid, N-[4-(3-fluorophenyl)-2-thiazolyl]-, 2,2,2-trifluoroethyl ester
CAS No.1311314-21-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVSXA099 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVFMX546 route compound structure diagram
    ACVFMX546446065-20-9 In Stock
  2. Plus
  3. ACCDJG914 route compound structure diagram
    ACCDJG91427746-99-2 In Stock
  4. Then
  5. ACVSXA099 route product structure diagram
    ACVSXA0991311314-21-2
Inquiry

2. ACVSXA099 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPORQ137 route compound structure diagram
    ACPORQ13753631-18-8 In Stock
  4. Then
  5. ACVSXA099 route product structure diagram
    ACVSXA0991311314-21-2
Inquiry

Comments (0)